Fragmin



Indications and Reactions:

Role Indications Reactions
Primary
Thrombosis Prophylaxis 36.7%
Deep Vein Thrombosis 10.2%
Pulmonary Embolism 7.7%
Prophylaxis 6.5%
Atrial Fibrillation 5.3%
Ill-defined Disorder 3.5%
Supplementation Therapy 3.2%
Hypertension 3.0%
Embolism 2.8%
Anticoagulant Therapy 2.7%
Thrombosis 2.3%
Dialysis 2.2%
Acne 2.0%
Ear Infection 2.0%
Hypercoagulation 2.0%
Sepsis 2.0%
Pain 1.8%
Hallucination 1.5%
Essential Hypertension 1.3%
Myocardial Infarction 1.3%
Pulmonary Embolism 30.9%
Thrombocytopenia 6.9%
Thrombosis 6.9%
Death 5.5%
Medical Device Complication 5.1%
Deep Vein Thrombosis 4.0%
Platelet Count Increased 4.0%
Cerebral Infarction 3.6%
Drug Exposure During Pregnancy 3.6%
Drug Ineffective 3.3%
Phlebitis 3.3%
Heparin-induced Thrombocytopenia 2.9%
Gastrointestinal Haemorrhage 2.5%
Haematoma 2.5%
Oedema Peripheral 2.5%
Pulmonary Infarction 2.5%
Renal Impairment 2.5%
Suicide Attempt 2.5%
Thrombocythaemia 2.5%
Injury Associated With Device 2.2%
Secondary
Drug Use For Unknown Indication 26.7%
Product Used For Unknown Indication 19.5%
Thrombosis Prophylaxis 8.7%
Prophylaxis 5.2%
Pain 5.0%
Deep Vein Thrombosis 4.3%
Infection Prophylaxis 4.3%
Hypertension 3.4%
Diarrhoea 3.1%
Nausea 2.5%
Pulmonary Embolism 2.3%
Atrial Fibrillation 2.1%
Sepsis 2.1%
Breast Cancer 1.6%
Malignant Melanoma 1.6%
Urinary Tract Infection 1.6%
Germ Cell Cancer 1.5%
Hallucination 1.5%
Pseudomonas Infection 1.5%
Anticoagulant Therapy 1.4%
Toxic Epidermal Necrolysis 17.7%
Liver Injury 6.2%
Pulmonary Embolism 6.2%
Vomiting 6.2%
White Blood Cell Count Decreased 6.2%
Thrombocytopenia 5.4%
Thrombosis 5.4%
Haematoma 4.6%
Phlebitis 4.6%
Rash 4.6%
Sepsis 4.6%
Stevens-johnson Syndrome 4.6%
Superinfection 4.6%
Urinary Tract Infection 3.8%
Contusion 3.1%
Haematuria 3.1%
Alanine Aminotransferase Increased 2.3%
Gastrointestinal Haemorrhage 2.3%
Pleural Effusion 2.3%
Pneumonia 2.3%
Concomitant
Product Used For Unknown Indication 25.3%
Drug Use For Unknown Indication 18.9%
Prophylaxis 9.6%
Pain 6.2%
Hypertension 5.4%
Anticoagulant Therapy 3.6%
Multiple Myeloma 3.3%
Thrombosis Prophylaxis 2.9%
Infection 2.9%
Non-small Cell Lung Cancer 2.7%
Infection Prophylaxis 2.4%
Neoplasm Malignant 2.2%
Sedation 2.1%
Schizoaffective Disorder 2.0%
Fluid Replacement 1.9%
Diffuse Large B-cell Lymphoma 1.9%
Nausea 1.8%
Colorectal Cancer Metastatic 1.7%
Allogenic Bone Marrow Transplantation Therapy 1.6%
Constipation 1.6%
Deep Vein Thrombosis 10.2%
Vomiting 9.6%
Pulmonary Embolism 8.2%
Thrombocytopenia 7.8%
Sepsis 6.2%
White Blood Cell Count Decreased 6.1%
Pneumonia 5.6%
Pyrexia 5.1%
Renal Failure Acute 4.5%
Death 4.3%
Respiratory Failure 4.3%
Thrombosis 4.2%
Weight Decreased 4.0%
Urinary Tract Infection 3.4%
Renal Failure 3.1%
Septic Shock 3.1%
Tachycardia 2.8%
Premature Baby 2.6%
Rhabdomyolysis 2.5%
Drug Interaction 2.2%
Interacting
Product Used For Unknown Indication 22.5%
Atrial Fibrillation 10.8%
Pneumonia Bacterial 9.8%
Psoriatic Arthropathy 9.8%
Thrombosis Prophylaxis 6.9%
Prophylaxis 5.9%
Back Disorder 4.9%
Acute Myocardial Infarction 3.9%
Deep Vein Thrombosis 2.9%
Depression 2.9%
Hip Arthroplasty 2.9%
Hypertension 2.9%
Lower Respiratory Tract Infection 2.9%
Pain 2.9%
Dyslipidaemia 2.0%
Rheumatoid Arthritis 2.0%
Diabetes Mellitus 1.0%
Folate Deficiency 1.0%
Hyperuricaemia 1.0%
Insomnia 1.0%
Blood Pressure Decreased 20.0%
Fall 13.3%
Gastrointestinal Inflammation 13.3%
Cytomegalovirus Test Positive 6.7%
Enterocolitis Haemorrhagic 6.7%
Haemorrhage 6.7%
Haemorrhoids 6.7%
Myocardial Infarction 6.7%
Occult Blood Positive 6.7%
Oesophagitis Ulcerative 6.7%
Wound Infection 6.7%